Unfortunately, the options for treating multidrug-resistant (MDR) Acinetobacter baumannii (A.
baumannii) infections are extremely limited. Recently, fosfomycin and minocycline were …

Recently, paradoxical combinations of colistin with anti-Gram-positive bacterial agents were
introduced as a treatment alternative for multidrug-resistant Acinetobacter baumannii …

The treatment of life-threatening infections due to carbapenem-resistant Acinetobacter
baumannii has become a serious challenge for physicians worldwide. Often, only colistin …

Acinetobacter baumannii is an important cause of nosocomial infection with increasing
carbapenem resistance. The aim of this study was to compare the efficacy of colistin+ …

Objectives: Successful therapy of carbapenem-resistant Acinetobacter baumannii strains
has been reported with colistin, but recently we argued against its use as monotherapy …

Combination therapy may be required for multidrug-resistant (MDR) Acinetobacter
baumannii. This study systematically investigated bacterial killing and emergence of colistin …

Due to increasing drug resistance, available antimicrobial options are limited in the
treatment of Acinetobacter baumannii infections. Particularly in cases caused by extensively …

Abstract Objectives Multidrug-resistant Pseudomonas aeruginosa (MDRP) is becoming a
serious problem in hospitals, especially in patients on ventilators. Recent data demonstrate …

Colistin-based combination therapy has become an important strategy to combat the
carbapenem-resistant Acinetobacter baumannii (CRAB). However, the optimal dosage …

Objective: This study investigated the minimum inhibitory concentration (MIC) values and in
vitro activity of colistin in combination with tigecycline against carbapenem-resistant …